Literature DB >> 21887726

Is there evidence to claim or deny association between variants of the multidrug resistance gene (MDR1 or ABCB1) and inflammatory bowel disease?

Elias Zintzaras1.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is a complex disease with a genetic background. Crohn's disease (CD) and ulcerative colitis (UC) are the two main types of IBD. There is indication that variants in the MDR1 gene are associated with development of IBD. However, the 20 published genetic association studies (GAS) for the three most popular variants in the MDR1 gene (C3435T, G2677T/A, and C1236T) have produced inclusive results.
METHODS: In order to decrease the uncertainty of pooled risk effects and to explore the trend and stability of the risk effects, a meticulous meta-analysis, including cumulative and recursive cumulative meta-analysis, of the GAS related to the MDR1 gene with susceptibility to IBD was conducted. The risk effects were estimated based on the odds ratio (OR) of the allele contrast and the generalized odds ratio (OR(G) ).
RESULTS: The analysis showed marginal significant association for the C3435T variant in UC: the risk estimate for the allele contrast was OR = 1.11 (1.00-1.22) and OR(G) = 1.12 (1.01-1.27), indicating that a subject with high mutational load has a 12% higher probability of being diseased. The respective cumulative meta-analysis indicated a downward trend of association, as evidence accumulates with the association being significant during the whole published period. The cumulative meta-analysis for the other variants showed lack of any trend of association. However, the recursive cumulative meta-analysis showed that there is no sufficient evidence for denying or claiming an association for all variants.
CONCLUSIONS: More evidence is needed to draw safe conclusions regarding the association of MDR1 variants and development of IBD.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887726     DOI: 10.1002/ibd.21728

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  11 in total

Review 1.  Intestinal and hepatic drug transporters: pharmacokinetic, pathophysiological, and pharmacogenetic roles.

Authors:  Tomohiro Terada; Daiki Hira
Journal:  J Gastroenterol       Date:  2015-03-14       Impact factor: 7.527

Review 2.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

3.  Different frequencies and effects of ABCB1 T3435C polymorphism on clinical and laboratory features of B cell chronic lymphocytic leukemia in Kurdish patients.

Authors:  Farzad Maroofi; Sabrieh Amini; Daem Roshani; Bayazid Ghaderi; Mohammad Abdi
Journal:  Tumour Biol       Date:  2015-01-15

Review 4.  CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.

Authors:  Jia-Jun Zhao; Di Wang; Hui Yao; Da-Wei Sun; Hong-Yu Li
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

5.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 6.  Pathogenesis of primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Emina Halilbasic; Peter Fickert; Michael Trauner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-12       Impact factor: 3.043

7.  Can the prevalence of symptoms in patients with inflammatory bowel disease be predicted by the analysis of multidrug resistance gene 1 polymorphisms?

Authors:  Miguel Angel Chiurillo
Journal:  Saudi J Gastroenterol       Date:  2013 Jul-Aug       Impact factor: 2.485

8.  Association of MDR1 G2677T polymorphism and leukemia risk: evidence from a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Li Xie; Yu He; Meng Li; Ruolin Li; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-10-20

9.  Determination of Vitamin D Serum Levels and Status of the C3435T Polymorphism of Multidrug Resistance 1 Gene in Southeastern Iranian Patients with Ulcerative Colitis.

Authors:  Mojgan Mohammadi; Mohammad Javad Zahedi; Amin Reza Nikpoor; Mehdi Nazem; Payam Khazaeli; Mohammad Mahdi Hayatbakhsh
Journal:  Middle East J Dig Dis       Date:  2015-10

10.  Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.

Authors:  XiaoCheng Lu; Linjun Tang; Kai Li; JinYu Zheng; Penglai Zhao; Yi Tao; Li-Xin Li
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.